{"id":"W2055346449","doi":"10.1016/s1470-2045(14)71205-7","title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1354,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Janssen Research and Development","keywords":"Abiraterone acetate; Prednisone; Medicine; Prostate cancer; Placebo; Internal medicine; Oncology; Castration; Urology; Abiraterone; Enzalutamide; Cancer; Androgen deprivation therapy; Hormone; Androgen receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002303499,0.001919901,0.00366889,0.0007445123,0.0004692406,0.001227529,0.001052096,0.001775616,0.004785404],"category_scores_gemma":[0.002228218,0.000850915,0.002714742,0.0006246045,0.001602116,0.00116557,0.0004503739,0.003089691,0.0009849538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007269862,"about_ca_system_score_gemma":0.001102609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001923151,"about_ca_topic_score_gemma":0.00371099,"domain_scores_codex":[0.9991294,0.0005222476,0.00006140306,0.0001152437,0.0000640947,0.0001076304],"domain_scores_gemma":[0.9985648,0.0005399777,0.0002923773,0.0001240304,0.00006622555,0.0004126971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9892036,0.00209019,0.0001714589,0.0003082028,0.0005066402,0.0000152984,0.00003347394,0.0002004411,0.001196743,0.00002815476,0.0001642574,0.006081481],"study_design_scores_gemma":[0.925648,0.07168847,0.001234106,0.00002230607,0.0005083923,0.00002302751,0.00002564413,0.0002571045,0.0002659917,0.0001131157,0.0001984419,0.00001538344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882672,0.006663199,0.0005371831,0.0004613051,0.0005479255,0.001402064,0.0007098213,0.000171577,0.001239582],"genre_scores_gemma":[0.9910575,0.003549463,0.0007068522,0.0004590677,0.0004936255,0.0008654722,0.0005327034,0.00002793236,0.002307419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004785404,"threshold_uncertainty_score":0.01600873,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1589090600127682,"score_gpt":0.4258998720708133,"score_spread":0.2669908120580451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}